Decoy Therapeutics Inc. (DCOY)

US · Healthcare · Biotechnology

$2.83-2.08%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-2.4M

EPS

$-4.46

Market cap

$1.7M

P/E

0.0

Forward P/E

0.0

P/B

0.41

Book value

$8.12

EPS (TTM)

$115.98

52-week high

$70.80

52-week low

$2.60

50-day MA

$4.21

200-day MA

$6.83

Beta

0.56

with an average price target of $30.00.

Insiders

10.44%

Institutions

9.67%

Fund	Stake
Tower Research Capital LLC	0.16%
UBS Group AG	0.08%
Morgan Stanley - Brokerage Accounts	0.00%
Danske Bank A/S.	0.00%
Advisory Services Network, LLC	0.00%
Warberg Asset Management LLC	0.00%
Geode Capital Management, LLC	0.00%
Advisor Group Holdings, Inc.	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Decoy Therapeutics Inc. — free to start.

Data updated 2026-09-18.